Scarica l'app Stockscreener
7.41
3.20%
0.23
Precedente Chiudi:
$7.18
Aprire:
$7.46
Volume 24 ore:
8.44M
Relative Volume:
1.68
Capitalizzazione di mercato:
$1.16B
Reddito:
$2.80M
Utile/perdita netta:
$-115.18M
Rapporto P/E:
-8.7454
EPS:
-0.8473
Flusso di cassa netto:
$-94.03M
1 W Prestazione:
+13.82%
1M Prestazione:
+49.85%
6M Prestazione:
+117.30%
1 anno Prestazione:
+169.45%
Intervallo 1D:
$7.11
$7.55
Intervallo di 1 settimana:
$6.362
$8.17
Portata 52W:
$2.24
$8.17
Absci Corp Stock (ABSI) Company Profile
Nome
Absci Corp
Settore
Industria
Telefono
(360) 949-1041
Indirizzo
18105 SE MILL PLAIN BLVD, VANCOUVER
Compare ABSI vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
7.41 | 1.16B | 2.80M | -115.18M | -94.03M | -0.8473 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-08 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-10-02 | Iniziato | JP Morgan | Overweight |
| 2025-07-03 | Ripresa | Morgan Stanley | Overweight |
| 2025-01-22 | Iniziato | Needham | Buy |
| 2024-10-02 | Iniziato | Guggenheim | Buy |
| 2024-07-03 | Iniziato | Morgan Stanley | Overweight |
| 2024-03-14 | Iniziato | Scotiabank | Sector Outperform |
| 2023-12-05 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2023-05-04 | Iniziato | H.C. Wainwright | Buy |
| 2022-08-12 | Downgrade | JP Morgan | Overweight → Underweight |
| 2022-07-18 | Iniziato | Truist | Buy |
| 2022-03-02 | Ripresa | Cowen | Market Perform |
| 2022-02-01 | Iniziato | Berenberg | Buy |
| 2021-11-10 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-08-16 | Iniziato | BofA Securities | Neutral |
| 2021-08-16 | Iniziato | Cowen | Market Perform |
| 2021-08-16 | Iniziato | Credit Suisse | Outperform |
| 2021-08-16 | Iniziato | Stifel | Hold |
Mostra tutto
Absci Corp Borsa (ABSI) Ultime notizie
Absci Corp (ABSI) Institutional Confidence - TradingKey
Absci Corp (ABSI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Absci Corp (ABSI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Absci Corp (ABSI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Absci Corp (ABSI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Absci Corp (ABSI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Absci Corp (ABSI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Absci Corp (ABSI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Absci Corp (ABSI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Leerink Starts Coverage on Absci Corporation (ABSI) - Insider Monkey
The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It - marketscreener.com
The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It - Benzinga
ABSI News | ABSCI CORP (NASDAQ:ABSI) - ChartMill
Absci Corp stock hits 52-week high at 7.44 USD By Investing.com - Investing.com Australia
ABSI Maintains Buy Rating -- Price Target Raised to $15.00 by Gu - GuruFocus
Absci Corp (ABSI) awards RSUs and stock options to director Szela - Stock Titan
Guggenheim Maintains Absci Corp(ABSI.US) With Buy Rating, Raises Target Price to $15 - Moomoo
Absci Corp stock hits 52-week high at 7.44 USD - Investing.com
MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ - marketscreener.com
Guggenheim raises Absci stock price target to $15 on hair loss drug - Investing.com Nigeria
MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery - 01net
Absci Insiders Land Bargain With Gains Of US$1.4m - 富途牛牛
Can AI crack 'undruggable' drugs? MindWalk, Absci weigh in - Stock Titan
Absci Corporation (ABSI) reports Q1 loss, misses revenue estimates - MSN
Absci (ABSI) Q1 2026 Earnings Call Transcript - AOL.com
Absci (ABSI) director Karen McGinnis granted RSUs and stock options - Stock Titan
Absci Corporation (ABSI) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026Slideshow - Seeking Alpha
Absci (NASDAQ: ABSI) director Mary Szela awarded RSUs and stock options - Stock Titan
Absci (NASDAQ: ABSI) director granted RSUs and stock options in equity awards - Stock Titan
[Form 4] Absci Corp Insider Trading Activity - Stock Titan
Absci (NASDAQ: ABSI) awards director 10,100 RSUs and 39,800 options - Stock Titan
Absci (ABSI) director Joseph Sirosh awarded RSUs and 39,800-share option - Stock Titan
Absci (NASDAQ: ABSI) reports 2026 shareholder votes on directors and auditor - Stock Titan
Absci climbs after new outperform at Leerink on catalyst path - MSN
ABSI Initiates Coverage by Leerink Partners -- Rating Outperform - GuruFocus
Leerink Partners Initiates Absci Corp(ABSI.US) With Buy Rating, Announces Target Price $12 - Moomoo
Absci Shares Rise After Leerink Partners Initiates Coverage at Outperform - Moomoo
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Absci stock granted New Outperform at Leerink (ABSI:NASDAQ) - Seeking Alpha
Absci Corp. Hits New 52-Week High of $7.33, Up 49.34% - MarketsMojo
The 1 AI Stock I'd Put in a Time Capsule and Open in 2036 - AOL.com
Absci Corp (ABSI) CFO reports 8,319-share tax withholding on RSU vesting - Stock Titan
ABSIAbsci Corp Stock Price and Quote - Finviz
Absci Corp. Stock Hits Day High with 17.83% Surge in Intraday Performance - Markets Mojo
BTIG Initiates Absci Corp(ABSI.US) With Buy Rating, Announces Target Price $9 - Moomoo
This biotech is leading what could be a 'GLP-1 moment for hair loss,' says BTIG - CNBC
ABSI Initiates Coverage On BTIG -- Price Target Announced at $9. - GuruFocus
BTIG initiates Absci stock with buy rating on AI drug platform By Investing.com - Investing.com South Africa
BTIG initiates Absci stock with buy rating on AI drug platform - Investing.com Australia
This Suncrete Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday - Benzinga
Earnings call transcript: Absci Corp misses revenue forecast in Q1 2026 - Investing.com Nigeria
Absci Corp Azioni (ABSI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
1.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):